enzalutamide
Showing 1 - 25 of 183
Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)
Not yet recruiting
- Prostatic Adenocarcinoma
- Enzalutamide
-
Seoul, Korea, Korea, Republic ofSamsung Medical Center
Aug 23, 2023
Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)
Not yet recruiting
- Prostate Cancer
- +2 more
- Enzalutamide
- M9241
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Metastatic Breast Cancer Trial in United States (Enzalutamide, Mifepristone, TPC)
Recruiting
- Metastatic Breast Cancer
- Enzalutamide
- +2 more
-
Birmingham, Alabama
- +5 more
Oct 19, 2023
Darolutamide, Enzalutamide and Apalutamide and How Well These
Not yet recruiting
- Non-metastatic Castration-resistant Prostate Cancer
- Apalutamide
- +2 more
-
Whippany, New JerseyBayer
Aug 25, 2023
Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)
Not yet recruiting
- Prostate Cancer
- DFMO
- +3 more
-
Baltimore, MarylandJohns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023
Medicines Called Enzalutamide and Abiraterone in People With
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
- Enzalutamide
- Abiraterone acetate
-
New York, New YorkPfizer Inc
Jul 21, 2023
Prostate Cancer Trial in Canada, United States (Enzalutamide, EPI-7386 with Enzalutamide)
Recruiting
- Prostate Cancer
- Enzalutamide
- EPI-7386 with Enzalutamide
-
Port Saint Lucie, Florida
- +8 more
Dec 13, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Prostatic Neoplasms
- MK-5684
- +6 more
- (no location specified)
Nov 21, 2023
Called DEAR, to Learn More About Treatment With Darolutamide,
Active, not recruiting
- Non-metastatic Castration-resistant Prostate Cancer
- Darolutamide (Nubeqa, BAY1841788)
- +2 more
-
Whippany, New JerseyBayer
Jan 13, 2023
Prostate Cancer Trial in Sacramento (Enzalutamide, Metformin Hydrochloride)
Active, not recruiting
- Prostate Cancer
- Enzalutamide
- Metformin Hydrochloride
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 4, 2022
Metastatic Prostate Cancer Trial in Toronto (Enzalutamide, Standard of Care SBRT and ADT)
Not yet recruiting
- Metastatic Prostate Cancer
- Enzalutamide
- Standard of Care SBRT and ADT
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Center
Oct 6, 2022
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United
Recruiting
- Hormone-Resistant Prostate Cancer
- +3 more
- Enzalutamide
- Ribociclib
-
Ann Arbor, Michigan
- +3 more
Feb 2, 2023
Metastatic Castration Resistant Prostate Cancer Trial in India (Enzalutamide, Androgen deprivation therapy (ADT))
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
- Enzalutamide
- Androgen deprivation therapy (ADT)
-
Ahmedabad, India
- +7 more
Jan 21, 2023
Prostatic Tumors, Castration-Resistant Trial in New York (TVB-2640, Enzalutamide)
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
- TVB-2640
- Enzalutamide
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
Feb 23, 2023
Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)
Terminated
- Metastatic Castration Resistant Prostate Cancer
- Prostate Neoplasms
- enzalutamide
- CRLX101
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 16, 2022
Prostate Cancer, Castration-resistant Prostate Cancer Trial in São Paulo (Docetaxel, Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Castration-resistant Prostate Cancer
- Docetaxel
- Enzalutamide
-
São Paulo, SP, BrazilInstituto do Câncer do Estado de São Paulo
Sep 14, 2022
Castration Resistant Metastatic Prostate Cancer Trial in Baltimore (Testosterone cypionate, Enzalutamide, Testosterone
Recruiting
- Castration Resistant Metastatic Prostate Cancer
- Testosterone cypionate
- +2 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Aug 4, 2022
COVID-19 Infection Trial in Bellinzona (Enzalutamide)
Terminated
- COVID-19 Infection
- Enzalutamide
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland (IOSI)
Aug 7, 2022
Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Enzalutamide
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Sep 26, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Enzalutamide
-
San Francisco, California
- +1 more
Sep 20, 2022